These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 31437521

  • 1. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A.
    Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
    [Abstract] [Full Text] [Related]

  • 2. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
    Gargano SM, Senarathne W, Feldman R, Florento E, Stafford P, Swensen J, Vranic S, Gatalica Z.
    Cancer Med; 2019 Dec; 8(17):7322-7329. PubMed ID: 31609094
    [Abstract] [Full Text] [Related]

  • 3. Molecular characterization of apocrine salivary duct carcinoma.
    Chiosea SI, Williams L, Griffith CC, Thompson LD, Weinreb I, Bauman JE, Luvison A, Roy S, Seethala RR, Nikiforova MN.
    Am J Surg Pathol; 2015 Jun; 39(6):744-52. PubMed ID: 25723113
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
    Hsieh MS, Lee YH, Jin YT, Kuo YJ.
    Virchows Arch; 2020 Oct; 477(4):581-592. PubMed ID: 32383006
    [Abstract] [Full Text] [Related]

  • 5. Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma.
    Jeong JS, Cho KJ, Kim D, Lee YS, Song JS.
    Pathol Res Pract; 2021 Dec; 228():153678. PubMed ID: 34781210
    [Abstract] [Full Text] [Related]

  • 6. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
    Ryu HJ, Koh YW, Yoon SO.
    Hum Pathol; 2018 Nov; 81():18-25. PubMed ID: 29753009
    [Abstract] [Full Text] [Related]

  • 7. Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.
    Udager AM, Chiosea SI.
    Head Neck Pathol; 2017 Sep; 11(3):288-294. PubMed ID: 28321773
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.
    Dalin MG, Desrichard A, Katabi N, Makarov V, Walsh LA, Lee KW, Wang Q, Armenia J, West L, Dogan S, Wang L, Ramaswami D, Ho AL, Ganly I, Solit DB, Berger MF, Schultz ND, Reis-Filho JS, Chan TA, Morris LG.
    Clin Cancer Res; 2016 Sep 15; 22(18):4623-33. PubMed ID: 27103403
    [Abstract] [Full Text] [Related]

  • 9. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A, Ptáková N, Santana T, Agaimy A, Ihrler S, Uro-Coste E, Thompson LDR, Bishop JA, Baněčkova M, Rupp NJ, Morbini P, de Sanctis S, Schiavo-Lena M, Vanecek T, Michal M, Leivo I.
    Am J Surg Pathol; 2019 Oct 15; 43(10):1303-1313. PubMed ID: 31162284
    [Abstract] [Full Text] [Related]

  • 10. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center.
    Mayer M, Wolber P, Prinz J, Jansen L, Esser J, Shabli S, Quaas A, Klußmann JP, Sharma SJ, Nachtsheim L, Arolt C.
    Eur Arch Otorhinolaryngol; 2024 Jul 15; 281(7):3779-3789. PubMed ID: 38587651
    [Abstract] [Full Text] [Related]

  • 11. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.
    Xu B, Dogan S, Haroon Al Rasheed MR, Ghossein R, Katabi N.
    Hum Pathol; 2019 Nov 15; 93():30-36. PubMed ID: 31430492
    [Abstract] [Full Text] [Related]

  • 12. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
    Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T.
    Cancer; 2005 Jun 15; 103(12):2526-33. PubMed ID: 15900577
    [Abstract] [Full Text] [Related]

  • 13. ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing.
    Ferguson DC, Momeni Boroujeni A, Zheng T, Mohanty AS, Ho AL, Arcila ME, Ross DS, Dogan S.
    Mod Pathol; 2022 Jul 15; 35(7):895-902. PubMed ID: 34963694
    [Abstract] [Full Text] [Related]

  • 14. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE.
    Cancer; 2016 Oct 15; 122(20):3136-3144. PubMed ID: 27379604
    [Abstract] [Full Text] [Related]

  • 15. High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
    Ku BM, Jung HA, Sun JM, Ko YH, Jeong HS, Son YI, Baek CH, Park K, Ahn MJ.
    J Transl Med; 2014 Oct 25; 12():299. PubMed ID: 25343854
    [Abstract] [Full Text] [Related]

  • 16. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.
    Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK.
    Clin Cancer Res; 2014 Dec 15; 20(24):6570-81. PubMed ID: 25316813
    [Abstract] [Full Text] [Related]

  • 17. Pure Apocrine Intraductal Carcinoma of Salivary Glands: Reassessment of Molecular Underpinnings and Behavior.
    Delfin L, Doff JJ, Gagan J, Flack A, Krane JF, Jo VY, Torell AG, Palsgrove D, Bishop JA.
    Head Neck Pathol; 2024 Jun 27; 18(1):58. PubMed ID: 38935197
    [Abstract] [Full Text] [Related]

  • 18. Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.
    Takase S, Kano S, Tada Y, Kawakita D, Shimura T, Hirai H, Tsukahara K, Shimizu A, Imanishi Y, Ozawa H, Okami K, Sato Y, Sato Y, Fushimi C, Okada T, Sato H, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Hanazawa T, Chazono H, Osamura RY, Nagao T.
    Oncotarget; 2017 Aug 29; 8(35):59023-59035. PubMed ID: 28938615
    [Abstract] [Full Text] [Related]

  • 19. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
    Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H, Nakajima T.
    Histopathology; 2017 Jan 29; 70(2):164-173. PubMed ID: 27079821
    [Abstract] [Full Text] [Related]

  • 20. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Boon E, Bel M, van Boxtel W, van der Graaf WTA, van Es RJJ, Eerenstein SEJ, Baatenburg de Jong RJ, van den Brekel MWM, van der Velden LA, Witjes MJH, Hoeben A, Willems SM, Bloemena E, Smit LA, Oosting SF, PALGA Group, Jonker MA, Flucke UE, van Herpen CML.
    Int J Cancer; 2018 Aug 15; 143(4):758-766. PubMed ID: 29492965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.